Explantation of Patent Foramen Ovale Closure Devices A Multicenter Survey

被引:54
作者
Verma, Swarnendra K. [1 ]
Tobis, Jonathan M. [1 ]
机构
[1] Univ Calif Los Angeles, UCLA Med Ctr, David Geffen Sch Med, Div Intervent Cardiol, Los Angeles, CA 90095 USA
关键词
adult congenital heart disease; device closure; explantation; patent foramen ovale; PFO closure; SYSTEMIC CONTACT-DERMATITIS; ATRIAL SEPTAL-DEFECT; CARDIAC PERFORATION; TRANSCATHETER CLOSURE; PERCUTANEOUS CLOSURE; AMPLATZER OCCLUDER; THROMBUS FORMATION; NICKEL RELEASE; IMPLANTATION; ALLERGY;
D O I
10.1016/j.jcin.2011.01.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives The aim of this study was to examine the frequency and causes of surgical explantation of patent foramen ovate (PFO) closure devices. Background PFO has been linked with cryptogenic strokes, recurrent transient neurologic deficits, sleep apnea, decompression illness, and migraines. Several randomized trials are in progress to determine whether PFO closure is preferable to medical management in the treatment of patients with cryptogenic strokes or migraine. The majority of PFO closures are performed off-label, because there is no U.S. Food and Drug Administration approval for use of any device to close a PFO. As data are accumulating on the benefits of implanting PFO closure devices, it is also important to examine complications that might occur. Methods We performed a database review to identify the frequency and causes of PFO device explantation, examining 18 PFO closure centers in Europe and the United States. Results Of the 13,736 percutaneous PFO device implantations performed over the past 9 years at these 18 institutions, 38 devices (0.28% [95% confidence interval: 0.20% to 0.37%]) required surgical removal. There were a wide range of causes cited for these removals. The most common cause for explantation was chest pain (n = 14), often determined to be secondary to nickel allergy to the PFO device. Other causes for explantation included persistence of a residual shunt (n = 12), the presence of thrombus on the device (n = 4), pericardial effusion (n = 2), perforation of the atrium or aortic root (n = 2), recurrent strokes (n = 1), the development of endocarditis (n = 1), and undocumented reasons (n = 2). Conclusions The vast majority of PFO closure procedures are performed safely with minimal complications. However, there is a small (0.28%) incidence of severe long-term problems associated with PFO closure that might require surgical removal of the device. In addition, the frequency of surgical explantation was found to be device-dependent; some of these devices seem to be safer than others. (J Am Coll Cardiol Intv 2011;4: 579-85) (C) 2011 by the American College of Cardiology Foundation
引用
收藏
页码:579 / 585
页数:7
相关论文
共 50 条
[31]   Xtrace: Novel Bioresorbable Device for Patent Foramen Ovale Closure [J].
Abu Ajamieh, Sara ;
Mindroc-Filimon, Diana ;
Mozo, Irene ;
Rocha, Isabel .
BIODEVICES: PROCEEDINGS OF THE 13TH INTERNATIONAL JOINT CONFERENCE ON BIOMEDICAL ENGINEERING SYSTEMS AND TECHNOLOGIES, VOL 1: BIODEVICES, 2020, 2020, :344-349
[32]   Patent Foramen Ovale Closure With the Gore Septal Occluder: Initial UK Experience [J].
Thomson, John D. ;
Hildick-Smith, David ;
Clift, Paul ;
Morgan, Gareth ;
Daniels, Matthew ;
Henderson, Robert ;
Spence, Mark S. ;
Mahadevan, Vaikom S. ;
Crossland, David ;
Ormerod, Oliver .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2014, 83 (03) :467-473
[33]   Patent foramen ovale [J].
Alakbarzade, Vafa ;
Keteepe-Arachi, Tracey ;
Karsan, Nazia ;
Ray, Robin ;
Pereira, Anthony C. .
PRACTICAL NEUROLOGY, 2020, 20 (03) :225-233
[34]   Anatomical predictors for suture-based closure of the patent foramen ovale: A multicenter experience [J].
Witte, Lars S. ;
Renkens, Mick P. L. ;
Gasecka, Aleksandra ;
el Bouziani, Abdelhak ;
de Winter, Robbert J. ;
Tijssen, Jan G. P. ;
Stella, Pieter R. ;
Leibundgut, Gregor ;
Voskuil, Michiel .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2023, 102 (02) :273-280
[35]   Device closure of residual shunt after percutaneous closure of patent foramen ovale [J].
Majunke, Nicolas ;
Wallenborn, Julia ;
Baranowski, Andreas ;
Wunderlich, Nina ;
Sievert, Horst .
EUROINTERVENTION, 2010, 5 (07) :833-837
[36]   Percutaneous closure of patent foramen ovale [J].
Schieffer, B .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2006, 131 (14) :770-770
[37]   Percutaneous patent foramen ovale closure: outcomes with the Premere and Amplatzer devices [J].
Bissessor, Naylin ;
Wong, Allison W. ;
Hourigan, Lisa A. ;
Jayasinghe, Rohan S. ;
Scalia, Greg S. ;
Burstow, Darryl J. ;
Griffiths, Lyn R. ;
Savage, Michael ;
Walters, Darren L. .
CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2011, 12 (03) :164-169
[38]   Relationship between patent foramen ovale anatomical features and residual shunt after patent foramen ovale closure [J].
Rie Nakayama ;
Yoichi Takaya ;
Teiji Akagi ;
Rika Takemoto ;
Madoka Haruna ;
Mitsutaka Nakashima ;
Takashi Miki ;
Koji Nakagawa ;
Norihisa Toh ;
Kazufumi Nakamura .
Cardiovascular Intervention and Therapeutics, 2024, 39 :200-206
[39]   Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale [J].
Hornung, Marius ;
Bertog, Stefan C. ;
Franke, Jennifer ;
Id, Dani ;
Taaffe, Margaret ;
Wunderlich, Nina ;
Vaskelyte, Laura ;
Hofmann, Ilona ;
Sievert, Horst .
EUROPEAN HEART JOURNAL, 2013, 34 (43) :3362-3369
[40]   Amplatzer Patent Foramen Ovale Occluder Device-Related Complications [J].
Iskander, Beshoy ;
Anwer, Fatima ;
Oliveri, Federico ;
Fotios, Kakargias ;
Panday, Priyanka ;
Franchini, Ana P. Arcia ;
Hamid, Pousette .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (04)